Copyright
©The Author(s) 2020.
World J Gastroenterol. Dec 14, 2020; 26(46): 7405-7415
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7405
Published online Dec 14, 2020. doi: 10.3748/wjg.v26.i46.7405
Group | Number of cases | Age in yr, mean ± SD | Gender of cases, M/F | NRS score, mean ± SD | Total bilirubin as µmol/L, mean ± SD | Jaundice duration in d, mean ± SD | PTCD cases |
TPN group | 30 | 58.90 ± 7.42 | 18/12 | 4.03 ± 0.78 | 100.26 ± 19.18 | 21.26 ± 9.16 | 16 |
EEN + PN group | 26 | 59.08 ± 7.64 | 15/11 | 4.08 ± 0.78 | 96.50 ± 18.01 | 18.96 ± 8.89 | 18 |
t or χ2 | 0.089 | 0.031 | 0.239 | 0.753 | 0.950 | 1.476 | |
P value | 0.9291 | 0.8612 | 0.8121 | 0.4551 | 0.3461 | 0.2242 |
- Citation: Ma BQ, Chen SY, Jiang ZB, Wu B, He Y, Wang XX, Li Y, Gao P, Yang XJ. Effect of postoperative early enteral nutrition on clinical outcomes and immune function of cholangiocarcinoma patients with malignant obstructive jaundice. World J Gastroenterol 2020; 26(46): 7405-7415
- URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7405.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i46.7405